Compare · CMPI vs HWKN
CMPI vs HWKN
Side-by-side comparison of Checkmate Pharmaceuticals Inc. (CMPI) and Hawkins Inc. (HWKN): market cap, price performance, sector, and recent activity on the wire.
Summary
- CMPI operates in Consumer Durables, while HWKN operates in Consumer Discretionary - the two are in different parts of the market.
- HWKN is the larger of the two at $3.24B, about 68.3x CMPI ($47.4M).
- HWKN has hit the wire 2 times in the past 4 weeks while CMPI has been quiet.
- HWKN has more recent analyst coverage (6 ratings vs 1 for CMPI).
- Company
- Checkmate Pharmaceuticals Inc.
- Hawkins Inc.
- Price
- $10.49+0.00%
- $155.10+1.55%
- Market cap
- $47.4M
- $3.24B
- 1M return
- -
- -6.34%
- 1Y return
- -
- +13.07%
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 0
- 2
- Recent ratings
- 1
- 6
Checkmate Pharmaceuticals Inc.
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. The company has strategic alliances with Merck KGaA and Pfizer. Checkmate Pharmaceuticals, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Hawkins Inc.
Hawkins, Inc. blends, manufactures, and distributes chemicals and other specialty ingredients in the United States and internationally. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. This segment primarily provides acids, alkalis, and industrial and food-grade salts. It also receives, stores, and distributes various chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. In addition, this segment manufactures sodium hypochlorite and agricultural products, as well as various food-grade products that include liquid phosphates, lactates, and other blended products; repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals, and contract and private label bleach packaging. The Water Treatment segment offers chemicals, equipment, and solutions for potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool and agriculture water. The Health and Nutrition segment offers ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products. Its products portfolio includes minerals, botanicals and herbs, vitamins and amino acids, excipients, joint products, sweeteners, and enzymes. The company was founded in 1938 and is headquartered in Roseville, Minnesota.
Latest CMPI
- Axonis Therapeutics Announces $115 Million Series A Financing
- venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies
- SEC Form 15-12B filed by Checkmate Pharmaceuticals Inc.
- SEC Form SC 13G/A filed by Checkmate Pharmaceuticals Inc. (Amendment)
- SEC Form SC 13D/A filed by Checkmate Pharmaceuticals Inc. (Amendment)
- SEC Form SC 13D/A filed by Checkmate Pharmaceuticals Inc. (Amendment)
- SEC Form SC 13D filed by Checkmate Pharmaceuticals Inc.
- SEC Form EFFECT filed by Checkmate Pharmaceuticals Inc.
- Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers $2.5M Milestone Payment to XOMA
- SEC Form 25-NSE filed by Checkmate Pharmaceuticals Inc.
Latest HWKN
- New insider Louismet Dan claimed ownership of 6 shares (SEC Form 3)
- Hawkins Inc. filed SEC Form 8-K: Leadership Update
- VP HEALTH AND NUTRITION Rozeboom Shirley A. covered exercise/tax liability with 3,608 shares and was granted 1,906 shares, decreasing direct ownership by 4% to 34,088 units (SEC Form 4)
- VP - WATER TREATMENT GROUP Lange Douglas A. was granted 1,994 shares, increasing direct ownership by 8% to 27,147 units (SEC Form 4)
- EXECUTIVE VP AND CFO Oldenkamp Jeffrey P. was granted 8,435 shares, increasing direct ownership by 9% to 102,818 units (SEC Form 4)
- VICE PRESIDENT OF OPERATIONS Grahek Drew M. was granted 2,697 shares, increasing direct ownership by 8% to 37,136 units (SEC Form 4)
- VP-INDUSTRIAL SOLUTIONS GROUP Mangine David J. was granted 1,906 shares, increasing direct ownership by 7% to 27,763 units (SEC Form 4)
- VP of Food and Health Sciences Jones Gregory Alan was granted 1,970 shares, increasing direct ownership by 24% to 10,144 units (SEC Form 4)
- CEO AND PRESIDENT Hawkins Patrick H. was granted 16,934 shares, increasing direct ownership by 6% to 321,726 units (SEC Form 4)
- SEC Form 10-K filed by Hawkins Inc.